HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilia Scalzulli Selected Research

Emilia Scalzulli Research Topics

Disease

32BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2024 - 12/2017
6Primary Myelofibrosis (Myelosclerosis)
02/2024 - 08/2019
6Neoplasms (Cancer)
02/2024 - 08/2019
3Polycythemia Vera
01/2023 - 10/2020
3Splenomegaly
01/2023 - 08/2019
3Anemia
01/2021 - 01/2019
2Myeloid Leukemia (Leukemia, Myelocytic)
01/2023 - 12/2020
2Hypertension (High Blood Pressure)
01/2023 - 07/2020
2Leukemia
06/2022 - 01/2021
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 08/2019
1Inflammation (Inflammations)
02/2024
1Cardiovascular Diseases (Cardiovascular Disease)
11/2023
1Carcinoma (Carcinomatosis)
01/2023
1Hematologic Diseases (Blood Diseases)
01/2023
1Infections
01/2023
1Melanoma (Melanoma, Malignant)
01/2023
1Skin Neoplasms (Skin Cancer)
01/2023
1Thrombocytosis (Thrombocythemia)
01/2023
1Merkel Cell Carcinoma
01/2023
1Abdominal Pain (Pain, Abdominal)
01/2023
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2023
1Stroke (Strokes)
01/2023
1Chronic Obstructive Pulmonary Disease (COPD)
01/2023
1Disease Progression
11/2022
1Residual Neoplasm
01/2022
1Dyslipidemias (Dyslipidemia)
08/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Hydrocephalus (Hydrocephaly)
01/2021
1Atrial Fibrillation
12/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020
1Multiple Myeloma
01/2018

Drug/Important Bio-Agent (IBA)

21Tyrosine Kinase InhibitorsIBA
02/2024 - 12/2017
8ruxolitinibIBA
02/2024 - 08/2019
7Imatinib Mesylate (Gleevec)FDA Link
09/2023 - 01/2019
6nilotinibFDA Link
11/2023 - 01/2019
6ponatinibIBA
11/2023 - 01/2019
3asciminibIBA
01/2023 - 08/2021
3Dasatinib (BMS 354825)FDA Link
01/2023 - 01/2019
2LDL Lipoproteins (beta Lipoproteins)IBA
08/2021 - 01/2020
2Phosphotransferases (Kinase)IBA
12/2020 - 08/2019
2AnticoagulantsIBA
12/2020 - 12/2020
2Azacitidine (5 Azacytidine)FDA Link
10/2020 - 08/2019
2ErythropoietinFDA Link
09/2020 - 01/2019
1Biomarkers (Surrogate Marker)IBA
02/2024
1avelumabIBA
01/2023
1Hemoglobins (Hemoglobin)IBA
01/2023
1Lamivudine (Epivir)FDA Link
01/2023
1Lenalidomide (CC 5013)FDA Link
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2021
1cemiplimabIBA
08/2021
1oxidized low density lipoproteinIBA
08/2021
1InterferonsIBA
01/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1Fibrinogen (Factor I)FDA Link
01/2021
1CytokinesIBA
10/2020
1DecitabineFDA Link
10/2020
1Angiotensin Receptor AntagonistsIBA
07/2020
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2020
1Triglycerides (Triacylglycerol)IBA
01/2020
1LDL CholesterolIBA
01/2020
1Hydroxyurea (Hydrea)FDA LinkGeneric
08/2019
1bosutinibIBA
01/2019
1Proteasome InhibitorsIBA
01/2018

Therapy/Procedure

6Therapeutics
09/2023 - 01/2018
1Immunotherapy
01/2023
1Secondary Prevention
01/2019